Lightcast Discovery Stock

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.

Sign up today and learn more about Lightcast Discovery Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Lightcast Discovery Stock

Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products. The company's mission is to push the boundaries of complex cell analysis. Using the Lightcast platform, the company is working with major pharmaceutical companies and leading academic institutes to enable them to discover more. The Lightcast platform allows precise and highly flexible independent control of thousands of droplets. By combining droplets containing different cells, reporters or other reagents we can perform complex workflows without the need to manipulate cells by hand. Lightcast Discovery was founded in 2019 by Cameron Frayling.

Funding History

September 2019$1.3M
August 2023$38.0M

Management

Chief Executive Officer

Paul Loeffen

CEO

Cameron Frayling

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo